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ABSTRACT 
 
Periodontal disease is a chronic bacterial infection characterized by persistent inflammation, connective tissue 
breakdown, and alveolar bone destruction. The result showed that it shows that scaling and root planing is efficient 
in reducing the gingival bleeding index scores, Probing Depth and Attachment Loss in chronic periodontitis patients. 
The study also proved that scaling and root planing was efficient in increasing  the OPG scores in chronic 
periodontitis patients. 
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Introduction 
 
Periodontal disease is a chronic bacterial infection 
characterized by persistent inflammation, connective 
tissue breakdown, and alveolar bone destruction. 
Simonet identified a novel secreted glycoprotein that 
regulates bone resorption[1]. The protein, termed 
Osteoprotegerin (OPG), is a novel member of the TNF 
receptor superfamily and can act as a soluble factor in 
the regulation of bone mass and imply a utility for 
OPG a member of the TNF family of cytokines that 
exists in transmembrane and soluble (cleaved) forms. 
The discovery of the RANK/RANKL/OPG system in 
the mid-1990s is of significant importance leading to a 
better understanding of the signalling system in the 
Regulation of Bone Metabolism [2,3]. 
Aims and objectives 
The aim of this study is to assess the value of  
Osteoprotegerin (OPG) in gcf, as an indicator of the 
severity of periodontal tissues destruction. 
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*Correspondence  
Dr. C K Anil 
Divya Jyoti College of Dental science and Research, 
Modinagar GZB, UP, India. 
E- Mail: drckbanil1515@gmail.com 
Materials and methods 
 
The present study was conducted in the Department of 
Periodontology and Implantology at Divya Jyoti 
College of Dental sciences and Research, Modinagar 
on subjects to estimate and compare the levels of 
Osteoprotegerin (OPG) in the gcf of the chronic 
periodontitis patients before and after scaling and root 
planning. A sample size of 50 patients of age group 30-
50 years with good systemic health were selected from 
the OPD. Patients so selected were studied into two 
groups Group I: Patients with chronic generalized 
periodontitis before  scaling and root planning Group 
II: Patients  after scaling and root planning[4-6]. 
 
Inclusion criteria 
• Both males and females patients 
 Patients aged between 30-50 years 
 Patients with minimum of 20 teeth 
 Patients with good systemic health and mental 
health status and Chronic generalized 
periodontitis patients with presence of moderate 
to advanced chronic periodontitis. (atleast 7 teeth 
with periodontal pocket deeper than 6 mm)[7-9]. 
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Exclusion criteria 
 Patients having systemic diseases like diabetes 
mellitus, rheumatoid arthritis, cardiovascular 
diseases, gastrointestinal disorders, respiratory 
diseases etc. 
 Patients with history of any periodontal surgery 
in past 6 months. 
 Pregnant and lactating females. 
 Smokers 
 History and/or presence of any other infections. 
FOR GCF COLLECTION  
1 to 5 µl calibrated volumetric microcapillary pipettes 
(Sigma Aldrich chemicals company ltd,USA).  
· Ependroff tubes 
FOR ELISA TEST   
Enzyme-linked immunosorbent assay  for   analysis of  
Osteoprotegrin ( OPG) (Immunoconcept India PVT. 
LTD.)  
 ELISA reader  
clinical parameters such as modified sulcus bleeding 
index  probing depth and relative attachment level were 
assessed.GCF sample was  collected for 15 seconds by 
calibrated volumetric microcapillary  pipettes and 
stored at -70°C till the time of assay.Biochemical 
analysis of GCF samples was done to estimate the level 
of  Osteoprotegrin ( OPG) using  ELISA kit ( BOSTER 
IMMUNOLEADER HUMAN  Osteoprotegrin ( OPG)  
ELISA KIT)[10-12]. 
 
 
Fig 1: Armamentarium (for clinical use) 
 
 
Fig 2: Armamentarium used for GCF collection 
 
 
Fig 3: Armamentarium (for GCF collection)  
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Fig 4: Thermocol box and dry ice for transportation of GCF sample 
 
 
Fig 5: Deep freezer used to store GCF sample 
 
 
Fig 6: ELSA kit for human OPG 
 
Fig 7:Microtiter pipettes 
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Fig 8: Adding samples into microtiter wells 
 
Fig 9: View of microtiter plate after first incubation 
 
Fig 10:Adding anti-human osteoprotegrin ( OPG)antibody working solution 
 
Fig 11: Washing the microtiter plate 
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Fig 12: View of microtiter plate 
 
Fig 13:Adding stop solution 
 
Fig 14:View of microtiter plate after adding stop solution 
 
 
Fig 15: ELISA reader 
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Fig 16: Operating on a patient 
Fig 17: Mechanism 
Results 
Table 1: Comparison of probing depth between baseline and 2 months period 
Gingival 
bleeding 
Baseline Mean 
2.44 
N 
50 
Std deviation 
0.33 
Std 
error 
0.047 
P 
Value 
0.001 
Significance 
Significant 
2 months 0.92 50 0.39 0.055 
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Fig 18: Comparison of gingival bleeding index scores between baseline and 2 months period 
Statistically significant difference shows that scaling and root planing is efficient in reducing the gingival bleeding 
index scores in chronic periodontitis patients. 
Table 2: Comparison of gingival bleeding index scores between baseline and 2 months period 
Probing depth Baseline Mean 
6.34 
N 
50 
Std deviation 
0.842 
Std error 
mean 
0.119 
P Value 
0.001 
Significance 
Significant 
2 months 3.05 50 0.904 0.121 
 
Fig 19: Comparison of probimg depth scores between baseline and 2 month period 
Statistically significant difference shows that scaling and root planing is efficient in reducing the Probing Depth in 
chronic periodontitis patients. 
Table 3: comparison of attachment level scores between baseline and 2 months period  
Attachment 
level 
Baseline Mean 
5.94 
N 
50 
Std deviation 
0.912 
Std error 
mean 
0.128 
P Value 
0.001 
Significance 
Significant 
2 months 1.72 50 0.847 0.119 
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Fig 20: Comparison of attachment level scores between baseline and 2 month period 
Statistically significant difference  shows that scaling and root planning is efficient in reducing the Attachment 
Level in chronic periodontitis patients 
Table 4: Comparison of opg level between baseline and 2 months period 
OPG Level Baseline Mean 
126.30 
N 
50 
Std deviation 
18.19 
Std error 
mean 
2.57 
P Value 
0.001 
Significance 
Significant 
2 months 176.62 50 7.07 1.00 
Fig 21: Comparison of attachment level scores between baseline and 2 month period 
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Statistically significant difference   shows that scaling and root planing is efficient in increasing the OPG Level in 
chronic periodontitis patients. 
Discussion 
OPG is a novel soluble decoy receptor that has been 
called the “bone protector” as it protects the skeleton 
from excessive bone resorption.opg cellular sources are 
osteoblasts, endothelial cells, fibroblasts, and vascular 
and smooth muscle cells. Receptor activator of nuclear 
factor ligand (rankl)is a ligand that belongs to TNF 
family. It is expressed by osteoblasts, activated T and B 
cells as well as production is stimulated by cytokines 
found in the GCF/saliva as a result of inflammation in 
individuals with periodontal disease. Osteoprotegerin 
on the other hand is a protein that has structural 
homology to RANK and is therefore a decoy receptor 
for RANKL. The ligand (RANKL) preferentially binds 
to it at the expense of its natural receptor RANK. Once 
the interaction between the ligand and the receptor is 
interrupted, differentiation of osteoclasts is prevented 
with reduction in bone resorption.When OPG 
concentrations are high, it binds to RANKL, inhibiting 
RANKL–RANK interaction, thus suppressing the 
terminal stage of osteoclastic differentiation and 
activation and blocking osteoclastogenesis.studies has 
reported similar results for OPG in gingival crevicular 
fluid (GCF)and saliva. Buduneli et al. evaluated the 
effects of initial periodontal treatment on GCF levels of 
IL-17, soluble RANKL, and OPG in smoking and 
nonsmoking patients with chronic periodontitis. 
Studies reported that the expression of OPG was found 
to be decreased, while RANKL was increased in 
periodontal diseases. Bostanci et al. have shown that 
RANKL and OPG gene expressions are differentially 
regulated in gingival tissues depending on the form of 
periodontal disease, and increased RANKL/OPG 
expression ratio may indicate the occurrence of 
periodontitis. 
Summary and conclusion 
The result showed that it shows that scaling and root 
planing is efficient in reducing the gingival bleeding 
index scores, Probing Depth and Attachment Loss in 
chronic periodontitis patients. The study also proved 
that scaling and root planing was efficient in increasing  
the OPG scores in chronic periodontitis patients. Since 
these parameters showed a positive correlation, it can 
be concluded that they can be used as predictors for 
change in OPG level and Osteoprotegerin can be used 
as a diagnostic marker in chronic periodontitis patients. 
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